FDA warning letter targets Medtronic drug system issues; U.N. takes steps on controlled substances;

> The FDA has sent Medtronic a warning letter over problems related to the manufacture of a number of its products, including motor corrosion in one of its drug infusion systems. FDA warning letter 

> Concerned about the number of controlled substances now showing up on Internet pharmacy sites, the United Nations International Narcotics Control Board (INCB) is working on a system that would allow companies to access import and export authorizations electronically. Item 

> The Indian Department of Industrial Policy and Promotion (DIPP) has been asked to consider allowing foreign investors to buy up to 49% percent of existing pharmaceutical companies when the majority of ownership will remain Indian. Story 

> United Drug, a pharmaceutical and healthcare services group, has picked up the U.K. and U.S. clinical supply business of Bilcare for €61 million ($75.3 million). Release 

> Ess Dee Aluminum, which makes packaging for drugmakers like Pfizer ($PFE) and AstraZeneca ($AZN), says its plan to reopen an India Foils plant near Kolkata, India, hit a snag because it is having problems wrapping up its lease renewal. Story 

And Finally... Despite the fact that Australia's pharmaceutical, medical and scientific device industries have seen greater export growth than any other manufacturing sectors in the last decade, they receive only cursory mention in a new report on the importance of the country's manufacturing industry. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.